BioCentury | Sep 15, 2017
Company News

Allergan partners with tribe to fight IPR

...related to Restasis with at least three entities, including Apotex Inc. (Toronto, Ontario) in 2015, TWi Pharmaceuticals Holding Inc....
BioCentury | Sep 9, 2017
Company News

Allergan partners with tribe to fight IPR

...related to Restasis with at least three entities, including Apotex Inc. (Toronto, Ontario) in 2015, TWi Pharmaceuticals Holding Inc....
BioCentury | Jul 14, 2017
Clinical News

Castle Creek begins Phase II/III of topical diacerein to treat epidermolysis bullosa simplex

...area (BSA) of lesions Status: Phase II/III started Milestone: NA Alex Himes AC-203 CCP-020 Castle Creek Pharmaceuticals LLC TWi Biotechnology Inc. TWi Pharmaceuticals Holding Inc. Caspase-1...
BioCentury | Dec 30, 2016
Financial News

TWi Pharmaceuticals financial update

...The TWi Biotechnology Inc. subsidiary of TWi Pharmaceuticals began the formal process to list on the Taipei...
...for at least six months or meet other requirements. TWi Pharmaceuticals Holding Inc. (TPEx:4180), Taipei, Taiwan Alex Himes TWi Biotechnology Inc. TWi Pharmaceuticals Holding Inc....
BioCentury | Oct 3, 2016
Financial News

Rare disease play Castle Creek raises $48M

...that blocks the activity of interleukin-1 (IL-1) beta. Castle Creek has rights to CCP-020 from TWi Pharmaceuticals Holding Inc....
BioCentury | Aug 31, 2016
Company News

Management tracks

...strategy officer. The subsidiary also hired Eva Ho as CFO. Ho previously was CFO at TWi Pharmaceuticals Holding Inc....
BioCentury | Aug 11, 2016
Distillery Therapeutics

Therapeutics: Integrin β3 (GPIIIa; CD61); integrin αvβ3 (CD51/CD61)

...Phase II testing for lung and head and neck cancers and preclinical testing for melanoma. TWi Pharmaceuticals Holding Inc....
BioCentury | May 12, 2016
Targets & Mechanisms

Another shot at the flu

...of people that normally die of influenza." At least two companies, Vertex Pharmaceuticals Inc. and TWi Pharmaceuticals Holding Inc....
...Diseases (NIAID), Bethesda, Md. Novartis AG (NYSE:NVS; SIX:NOVN) Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France TWi Pharmaceuticals Holding Inc....
BioCentury | Jan 11, 2016
Clinical News

AC-201 CR: Interim Phase IIa data

...140 patients. Patients will receive febuxostat plus AC-201 CR or placebo in the second cohort. TWi Pharmaceuticals Holding Inc....
BioCentury | Nov 18, 2015
Company News

Management tracks

...and drug delivery play TWi Pharmaceuticals Holding Inc. (TPEx:4180) hired Rick Pallokat as EVP of its U.S. subsidiary, TWi Pharmaceuticals...
Items per page:
1 - 10 of 34
BioCentury | Sep 15, 2017
Company News

Allergan partners with tribe to fight IPR

...related to Restasis with at least three entities, including Apotex Inc. (Toronto, Ontario) in 2015, TWi Pharmaceuticals Holding Inc....
BioCentury | Sep 9, 2017
Company News

Allergan partners with tribe to fight IPR

...related to Restasis with at least three entities, including Apotex Inc. (Toronto, Ontario) in 2015, TWi Pharmaceuticals Holding Inc....
BioCentury | Jul 14, 2017
Clinical News

Castle Creek begins Phase II/III of topical diacerein to treat epidermolysis bullosa simplex

...area (BSA) of lesions Status: Phase II/III started Milestone: NA Alex Himes AC-203 CCP-020 Castle Creek Pharmaceuticals LLC TWi Biotechnology Inc. TWi Pharmaceuticals Holding Inc. Caspase-1...
BioCentury | Dec 30, 2016
Financial News

TWi Pharmaceuticals financial update

...The TWi Biotechnology Inc. subsidiary of TWi Pharmaceuticals began the formal process to list on the Taipei...
...for at least six months or meet other requirements. TWi Pharmaceuticals Holding Inc. (TPEx:4180), Taipei, Taiwan Alex Himes TWi Biotechnology Inc. TWi Pharmaceuticals Holding Inc....
BioCentury | Oct 3, 2016
Financial News

Rare disease play Castle Creek raises $48M

...that blocks the activity of interleukin-1 (IL-1) beta. Castle Creek has rights to CCP-020 from TWi Pharmaceuticals Holding Inc....
BioCentury | Aug 31, 2016
Company News

Management tracks

...strategy officer. The subsidiary also hired Eva Ho as CFO. Ho previously was CFO at TWi Pharmaceuticals Holding Inc....
BioCentury | Aug 11, 2016
Distillery Therapeutics

Therapeutics: Integrin β3 (GPIIIa; CD61); integrin αvβ3 (CD51/CD61)

...Phase II testing for lung and head and neck cancers and preclinical testing for melanoma. TWi Pharmaceuticals Holding Inc....
BioCentury | May 12, 2016
Targets & Mechanisms

Another shot at the flu

...of people that normally die of influenza." At least two companies, Vertex Pharmaceuticals Inc. and TWi Pharmaceuticals Holding Inc....
...Diseases (NIAID), Bethesda, Md. Novartis AG (NYSE:NVS; SIX:NOVN) Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France TWi Pharmaceuticals Holding Inc....
BioCentury | Jan 11, 2016
Clinical News

AC-201 CR: Interim Phase IIa data

...140 patients. Patients will receive febuxostat plus AC-201 CR or placebo in the second cohort. TWi Pharmaceuticals Holding Inc....
BioCentury | Nov 18, 2015
Company News

Management tracks

...and drug delivery play TWi Pharmaceuticals Holding Inc. (TPEx:4180) hired Rick Pallokat as EVP of its U.S. subsidiary, TWi Pharmaceuticals...
Items per page:
1 - 10 of 34